Vertex Pharmaceuticals (VRTX)

Retained Earnings

$15.69B

Quarterly · Period ending: · USD

VRTX logo

VRTX Retained Earnings

Latest reported$15.69B
VRTX Quarterly Retained Earnings (-$6.20M → $15.69B)
High-resolution chart · PNG

VRTX retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-251,462,000
-239,355,000
-230,485,000
-219,231,000
-194,373,000
-206,986,000
-190,800,000
-192,500,000
-178,300,000
-167,400,000
-149,900,000
-137,300,000
-135,000,000
-125,200,000
-116,800,000
-110,000,000
-104,100,000
-102,700,000
-96,900,000
-93,100,000
-86,700,000
-64,400,000
-56,900,000
-56,100,000
-49,100,000
-40,100,000
-35,400,000
-30,500,000
-26,600,000
-21,100,000
-17,800,000
-26,600,000
-23,900,000
-23,200,000
-19,900,000
-17,200,000
-14,900,000
-13,000,000
-11,400,000
-10,000,000
-8,800,000
-6,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.